$HQY
HEALTHEQUITY, INC. Stock $hqy

$hqy Overview Financials Valuation SEC Filings Company Website

2017 Q4 Form 10-Q Financial Statement

#000142833617000028 Filed on December 07, 2017

Income Statement

Concept	2017 Q4	2017 Q1	2016 Q4
Revenue	$56.79M	$46.81M	$43.36M
YoY Change	30.98%	30.45%	41.9%
Cost Of Revenue	$23.06M	$22.59M	$17.47M
YoY Change	32.03%	29.39%	35.61%
Gross Profit	$33.73M	$24.23M	$25.89M
YoY Change	30.27%	31.46%	46.48%
Gross Profit Margin	59.39%	51.76%	59.71%
Selling, General & Admin	$12.14M	$10.40M	$9.557M
YoY Change	27.07%	26.83%	46.04%
% of Gross Profit	36.01%	42.92%	36.91%
Research & Development	$6.866M	$6.500M	$6.209M
YoY Change	10.58%	32.65%	40.51%
% of Gross Profit	20.36%	26.83%	23.98%
Depreciation & Amortization	$700.0K	$3.700M	$523.0K
YoY Change	33.84%	27.59%	34.45%
% of Gross Profit	2.08%	15.27%	2.02%
Operating Expenses	$20.17M	$18.05M	$16.85M
YoY Change	19.68%	28.25%	48.16%
Operating Profit	$13.56M	$6.181M	$9.042M
YoY Change	49.99%	41.8%	43.43%
Interest Expense		$0.00
YoY Change
% of Operating Profit		0.0%
Other Income/Expense, Net	-$395.0K	-$158.0K	-$256.0K
YoY Change	54.3%	150.79%	-311.57%
Pretax Income	$13.17M	$6.000M	$8.786M
YoY Change	49.86%	39.53%	36.75%
Income Tax	$2.685M	$1.961M	$2.778M
% Of Pretax Income	20.39%	32.68%	31.62%
Net Earnings	$10.48M	$4.062M	$6.008M
YoY Change	74.47%	29.86%	47.0%
Net Earnings / Revenue	18.46%	8.68%	13.86%
Basic Earnings Per Share	$0.17	$0.07	$0.10
Diluted Earnings Per Share	$0.17	$0.07	$0.10
COMMON SHARES
Basic Shares Outstanding	60.56M shares	59.63M shares	58.94M shares
Diluted Shares Outstanding	61.87M shares		60.07M shares

Balance Sheet

Concept	2017 Q4	2017 Q1	2016 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$225.1M	$180.4M	$165.7M
YoY Change	35.85%	45.72%	32.45%
Cash & Equivalents	$184.4M	$140.0M	$125.3M
Short-Term Investments	$40.70M	$40.40M	$40.40M
Other Short-Term Assets	$6.100M	$2.867M	$5.400M
YoY Change	12.96%	68.35%	0.0%
Inventory	$169.0K	$592.0K	$944.0K
Prepaid Expenses	$6.106M	$2.867M	$5.352M
Receivables	$21.46M	$17.00M	$14.06M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$252.8M	$200.8M	$186.1M
YoY Change	35.88%	40.39%	31.75%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.789M	$5.170M	$5.373M
YoY Change	26.35%	47.46%	48.67%
Goodwill	$4.651M	$4.651M	$4.651M
YoY Change	0.0%	0.0%	0.0%
Intangibles	$85.45M	$65.02M	$65.69M
YoY Change	30.08%	-2.72%	7.62%
Long-Term Investments	$206.0K		$281.0K
YoY Change	-26.69%		0.0%
Other Assets	$1.760M	$1.861M	$2.003M
YoY Change	-12.13%	6.34%	38.71%
Total Long-Term Assets	$103.3M	$78.32M	$78.41M
YoY Change	31.75%	2.05%	10.84%
TOTAL ASSETS
Total Short-Term Assets	$252.8M	$200.8M	$186.1M
Total Long-Term Assets	$103.3M	$78.32M	$78.41M
Total Assets	$356.1M	$279.1M	$264.5M
YoY Change	34.65%	27.0%	24.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.295M	$3.221M	$1.582M
YoY Change	108.28%	32.5%	-34.41%
Accrued Expenses	$9.680M	$3.760M	$4.195M
YoY Change	130.75%	98.0%	37.41%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$19.48M	$15.70M	$10.44M
YoY Change	86.64%	29.71%	11.46%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$2.200M	$1.500M	$1.300M
YoY Change	69.23%	650.0%	550.0%
Total Long-Term Liabilities	$2.226M	$1.493M	$1.444M
YoY Change	54.16%	-64.72%	-66.22%
TOTAL LIABILITIES
Total Short-Term Liabilities	$19.48M	$15.70M	$10.44M
Total Long-Term Liabilities	$2.226M	$1.493M	$1.444M
Total Liabilities	$21.70M	$17.20M	$11.88M
YoY Change	82.69%	5.25%	-12.89%
SHAREHOLDERS EQUITY
Retained Earnings	$79.35M	$29.99M	$25.92M
YoY Change	206.1%	730.84%	5289.4%
Common Stock	$6.000K	$6.000K	$6.000K
YoY Change	0.0%	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$334.4M	$261.9M	$252.6M
YoY Change
Total Liabilities & Shareholders Equity	$356.1M	$279.1M	$264.5M
YoY Change	34.65%	27.0%	24.77%

Cashflow Statement

Concept	2017 Q4	2017 Q1	2016 Q4
OPERATING ACTIVITIES
Net Income	$10.48M	$4.062M	$6.008M
YoY Change	74.47%	29.86%	47.0%
Depreciation, Depletion And Amortization	$700.0K	$3.700M	$523.0K
YoY Change	33.84%	27.59%	34.45%
Cash From Operating Activities	$22.10M	$14.60M	$15.50M
YoY Change	42.58%	89.61%	34.78%
INVESTING ACTIVITIES
Capital Expenditures	-$9.800M	-$3.200M	-$4.300M
YoY Change	127.91%	-65.59%	-88.32%
Acquisitions
YoY Change
Other Investing Activities	-$3.000M	-$100.0K	-$100.0K
YoY Change	2900.0%	0.0%	0.0%
Cash From Investing Activities	-$12.70M	-$3.300M	-$4.400M
YoY Change	188.64%	-64.89%	-88.04%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	5.200M	3.300M	5.100M
YoY Change	1.96%	1550.0%	240.0%
NET CHANGE
Cash From Operating Activities	22.10M	14.60M	15.50M
Cash From Investing Activities	-12.70M	-3.300M	-4.400M
Cash From Financing Activities	5.200M	3.300M	5.100M
Net Change In Cash	14.60M	14.60M	16.20M
YoY Change	-9.88%	-1073.33%	-168.07%
FREE CASH FLOW
Cash From Operating Activities	$22.10M	$14.60M	$15.50M
Capital Expenditures	-$9.800M	-$3.200M	-$4.300M
Free Cash Flow	$31.90M	$17.80M	$19.80M
YoY Change	61.11%	4.71%	-59.01%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2016Q4	hqy	Cost Of Services Card Costs CostOfServicesCardCosts	2331000	USD
	hqy	Cost Of Services Card Costs CostOfServicesCardCosts	7748000	USD
CY2017Q4	hqy	Cost Of Services Card Costs CostOfServicesCardCosts	3027000	USD
	hqy	Cost Of Services Card Costs CostOfServicesCardCosts	9625000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--01-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
	dei	Document Period End Date DocumentPeriodEndDate	2017-10-31
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001428336
CY2017Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	60672608	shares
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	HEALTHEQUITY INC
CY2016Q4	hqy	Amortization Of Acquired Intangible AmortizationOfAcquiredIntangible	1083000	USD
	hqy	Amortization Of Acquired Intangible AmortizationOfAcquiredIntangible	3214000	USD
CY2017Q4	hqy	Amortization Of Acquired Intangible AmortizationOfAcquiredIntangible	1155000	USD
	hqy	Amortization Of Acquired Intangible AmortizationOfAcquiredIntangible	3320000	USD
CY2017Q1	hqy	Cash Cash Equivalents And Short Term Investments Fair Value Disclosure CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure	180359000	USD
CY2017Q4	hqy	Cash Cash Equivalents And Short Term Investments Fair Value Disclosure CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure	225078000	USD
CY2017Q4	hqy	Cost Method Investment Ownership Percentage CostMethodInvestmentOwnershipPercentage	0.02
CY2016Q4	hqy	Cost Of Services Custodial Costs CostOfServicesCustodialCosts	2461000	USD
	hqy	Cost Of Services Custodial Costs CostOfServicesCustodialCosts	7211000	USD
CY2017Q4	hqy	Cost Of Services Custodial Costs CostOfServicesCustodialCosts	2784000	USD
	hqy	Cost Of Services Custodial Costs CostOfServicesCustodialCosts	8370000	USD
CY2017Q4	hqy	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	2100000	USD
	hqy	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	12600000	USD
CY2017Q2	hqy	Lessee Leasing Arrangements Operating Leases Annual Initial Rent LesseeLeasingArrangementsOperatingLeasesAnnualInitialRent	513000	USD
CY2016Q4	hqy	Other Expenses Agreements OtherExpensesAgreements	93000	USD
	hqy	Other Expenses Agreements OtherExpensesAgreements	237000	USD
CY2017Q4	hqy	Other Expenses Agreements OtherExpensesAgreements	115000	USD
	hqy	Other Expenses Agreements OtherExpensesAgreements	341000	USD
	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Exercised ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitExercised	0.10
	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Forfeited ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitForfeited	3.50
	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Granted ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitGranted	41.28
CY2017Q1	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Outstanding ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding	0.10
CY2017Q4	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Outstanding ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding	0.10
	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Exercised ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitExercised	46.40
	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Forfeited ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitForfeited	46.40
	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Granted ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitGranted	51.44
CY2017Q1	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Outstanding ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding	44.53
CY2017Q4	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Outstanding ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding	51.44
CY2017Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	3221000	USD
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3295000	USD
CY2017Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	17001000	USD
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	21458000	USD
CY2017Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3760000	USD
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9680000	USD
CY2017Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6013000	USD
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7989000	USD
CY2017Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-165000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-188000	USD
CY2017Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	232114000	USD
CY2017Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	255245000	USD
CY2016Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2068000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6399000	USD
CY2017Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3665000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10468000	USD
CY2017Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	75000	USD
CY2017Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	100000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	53000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	97000	USD
CY2016Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2900000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	8100000	USD
CY2017Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3300000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	9200000	USD
CY2016Q4	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	702000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1900000	shares
CY2017Q4	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	834000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	729000	shares
CY2017Q1	us-gaap	Assets Assets	279136000	USD
CY2017Q4	us-gaap	Assets Assets	356117000	USD
CY2017Q1	us-gaap	Assets Current AssetsCurrent	200819000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	252811000	USD
CY2017Q1	us-gaap	Available For Sale Securities AvailableForSaleSecurities	40405000	USD
CY2017Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	40711000	USD
CY2017Q1	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	207000	USD
CY2017Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	271000	USD
CY2017Q1	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	472000	USD
CY2017Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	573000	USD
CY2017Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	207000	USD
CY2017Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	366000	USD
CY2017Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	25537000	USD
CY2017Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	15174000	USD
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	15440000	USD
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	15174000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-423000	USD
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate	40711000	USD
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis	41013000	USD
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	25573000	USD
CY2017Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	25537000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	569000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	238000	USD
CY2016Q4	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	2000000	USD
	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	5700000	USD
CY2017Q4	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	2100000	USD
	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	6300000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	83641000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	125346000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	139954000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	184367000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	139954000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	184367000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	41705000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	44413000	USD
CY2017Q1	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	180624000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	225380000	USD
CY2017Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2017Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2017Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	59538000	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	60652000	shares
CY2017Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	59538000	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	60652000	shares
CY2017Q1	us-gaap	Common Stock Value CommonStockValue	6000	USD
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	6000	USD
CY2017Q4	us-gaap	Cost Method Investments CostMethodInvestments	500000	USD
CY2016Q4	us-gaap	Cost Of Services CostOfServices	17467000	USD
	us-gaap	Cost Of Services CostOfServices	49430000	USD
CY2017Q4	us-gaap	Cost Of Services CostOfServices	23062000	USD
	us-gaap	Cost Of Services CostOfServices	65819000	USD
CY2017Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1615000	USD
CY2017Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	4656000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1880000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	5093000	USD
CY2017Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	37000	USD
CY2017Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	0	USD
CY2017Q1	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	1456000	USD
CY2017Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	2226000	USD
CY2016Q4	us-gaap	Depreciation Depreciation	523000	USD
	us-gaap	Depreciation Depreciation	1400000	USD
CY2017Q4	us-gaap	Depreciation Depreciation	697000	USD
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.346
CY2017Q4	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.204
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.088
CY2017Q4	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.164
	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.273
CY2016Q4	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.046
	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.012
	us-gaap	Depreciation Depreciation	2000000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9543000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	11142000	USD
CY2016Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.10
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.38
CY2017Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.17
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.69
CY2016Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.10
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.37
CY2017Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.17
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.67
CY2016Q4	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.316
CY2017Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	8722000	USD
CY2017Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	6503000	USD
CY2017Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	20200000	USD
CY2017Q4	us-gaap	Equity Method Investment Ownership Percentage EquityMethodInvestmentOwnershipPercentage	0.22
CY2017Q4	us-gaap	Equity Method Investments EquityMethodInvestments	206000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	15909000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	0	USD
CY2016Q4	us-gaap	Fees And Commissions Credit And Debit Cards FeesAndCommissionsCreditAndDebitCards	9610000	USD
	us-gaap	Fees And Commissions Credit And Debit Cards FeesAndCommissionsCreditAndDebitCards	31389000	USD
CY2017Q4	us-gaap	Fees And Commissions Credit And Debit Cards FeesAndCommissionsCreditAndDebitCards	11722000	USD
	us-gaap	Fees And Commissions Credit And Debit Cards FeesAndCommissionsCreditAndDebitCards	38122000	USD
CY2017Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	30908000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	40074000	USD
CY2017Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	95928000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	125524000	USD
CY2017Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	65020000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	85450000	USD
CY2016Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5166000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	15290000	USD
CY2017Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6252000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	18354000	USD
CY2017Q1	us-gaap	Goodwill Goodwill	4651000	USD
CY2017Q4	us-gaap	Goodwill Goodwill	4651000	USD
CY2016Q4	us-gaap	Goodwill Period Increase Decrease GoodwillPeriodIncreaseDecrease	0	USD
	us-gaap	Goodwill Period Increase Decrease GoodwillPeriodIncreaseDecrease	0	USD
CY2017Q4	us-gaap	Goodwill Period Increase Decrease GoodwillPeriodIncreaseDecrease	0	USD
	us-gaap	Goodwill Period Increase Decrease GoodwillPeriodIncreaseDecrease	0	USD
CY2016Q4	us-gaap	Gross Profit GrossProfit	25891000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	324000	USD
	us-gaap	Gross Profit GrossProfit	82126000	USD
CY2017Q4	us-gaap	Gross Profit GrossProfit	33727000	USD
	us-gaap	Gross Profit GrossProfit	103270000	USD
CY2016Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	8786000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	34097000	USD
CY2017Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	13167000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	45461000	USD
CY2016Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2778000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	11783000	USD
CY2017Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2700000	USD
CY2017Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2685000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4004000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4000000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-973000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-425000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-244000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4482000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1666000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2586000	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-3117000	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-2219000	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	1059000	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	770000	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	3955000	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	3027000	USD
CY2016Q4	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1135000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1355000	shares
CY2017Q4	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1306000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1543000	shares
CY2017Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	65020000	USD
CY2017Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	85450000	USD
CY2017Q1	us-gaap	Inventory Net InventoryNet	592000	USD
CY2017Q4	us-gaap	Inventory Net InventoryNet	169000	USD
CY2016Q4	us-gaap	Investment Advisory Management And Administrative Fees InvestmentAdvisoryManagementAndAdministrativeFees	14967000	USD
	us-gaap	Investment Advisory Management And Administrative Fees InvestmentAdvisoryManagementAndAdministrativeFees	43557000	USD
CY2017Q4	us-gaap	Investment Advisory Management And Administrative Fees InvestmentAdvisoryManagementAndAdministrativeFees	22105000	USD
	us-gaap	Investment Advisory Management And Administrative Fees InvestmentAdvisoryManagementAndAdministrativeFees	62709000	USD
CY2016Q4	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1100000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	2300000	USD
CY2017Q4	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1000000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	3100000	USD
CY2017Q1	us-gaap	Liabilities Liabilities	17196000	USD
CY2017Q4	us-gaap	Liabilities Liabilities	21704000	USD
CY2017Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	279136000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-523000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	356117000	USD
CY2017Q1	us-gaap	Liabilities Current LiabilitiesCurrent	15703000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	19478000	USD
CY2017Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1493000	USD
CY2017Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2226000	USD
CY2016Q4	us-gaap	Membership Dues Revenue On Going MembershipDuesRevenueOnGoing	18781000	USD
	us-gaap	Membership Dues Revenue On Going MembershipDuesRevenueOnGoing	56610000	USD
CY2017Q4	us-gaap	Membership Dues Revenue On Going MembershipDuesRevenueOnGoing	22962000	USD
	us-gaap	Membership Dues Revenue On Going MembershipDuesRevenueOnGoing	68258000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	20455000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	12320000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-9779000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-29790000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	31029000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	61883000	USD
CY2016Q4	us-gaap	Net Income Loss NetIncomeLoss	6008000	USD
	us-gaap	Net Income Loss NetIncomeLoss	22314000	USD
CY2017Q4	us-gaap	Net Income Loss NetIncomeLoss	10482000	USD
	us-gaap	Net Income Loss NetIncomeLoss	41457000	USD
CY2016Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-256000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-934000	USD
CY2017Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-395000	USD
CY2016Q4	us-gaap	Operating Expenses OperatingExpenses	16849000	USD
	us-gaap	Operating Expenses OperatingExpenses	47095000	USD
CY2017Q4	us-gaap	Operating Expenses OperatingExpenses	20165000	USD
	us-gaap	Operating Expenses OperatingExpenses	57286000	USD
CY2016Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	9042000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	35031000	USD
CY2017Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	13562000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	45984000	USD
CY2017Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1861000	USD
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1760000	USD
CY2016Q4	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-23000	USD
	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-36000	USD
CY2017Q4	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	7000	USD
	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-23000	USD
CY2016Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	5985000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	22278000	USD
CY2017Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	10489000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	41434000	USD
CY2016Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-256000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-934000	USD
CY2017Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-395000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-523000	USD
	us-gaap	Payments For Software PaymentsForSoftware	6799000	USD
	us-gaap	Payments For Software PaymentsForSoftware	7654000	USD
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	0	USD
CY2017Q4	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	3300000	USD
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	2882000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	15529000	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	275000	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	343000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2705000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3382000	USD
CY2017Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2017Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2017Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2017Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2867000	USD
CY2017Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	6106000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	4546000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	12320000	USD
CY2017Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	11183000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	14778000	USD
CY2017Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5170000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6789000	USD
CY2016Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6209000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	15827000	USD
CY2017Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6866000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	19905000	USD
CY2016Q4	us-gaap	Research And Development Expense Software Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost	2600000	USD
	us-gaap	Research And Development Expense Software Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost	6900000	USD
CY2017Q4	us-gaap	Research And Development Expense Software Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost	3000000	USD
	us-gaap	Research And Development Expense Software Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost	8900000	USD
CY2017Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	29985000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	79350000	USD
CY2016Q4	us-gaap	Revenues Revenues	43358000	USD
	us-gaap	Revenues Revenues	131556000	USD
CY2017Q4	us-gaap	Revenues Revenues	56789000	USD
	us-gaap	Revenues Revenues	169089000	USD
CY2016Q4	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4391000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	12764000	USD
CY2017Q4	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5892000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	15707000	USD
CY2016Q4	us-gaap	Service Management Costs ServiceManagementCosts	12675000	USD
	us-gaap	Service Management Costs ServiceManagementCosts	34471000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	32.64
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	145000	shares
CY2017Q4	us-gaap	Service Management Costs ServiceManagementCosts	17251000	USD
	us-gaap	Service Management Costs ServiceManagementCosts	47824000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	6399000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	10468000	USD
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.3815
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.3779
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.3837
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.3801
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.3815
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.3779
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0118
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0127
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0155
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0207
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0118
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0118
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0118
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	14.42
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	420000	shares
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	131529000	USD
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	107808000	USD
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4716000	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3886000	shares
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	18.36
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	22.49
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	107808000	USD
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	1168000	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	3886000	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	22.49
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	11.23
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	42.72
CY2017Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y6M
CY2017Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	41797000	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y6M24D
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y7M6D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y6M6D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P7Y6M6D
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1105000	shares
CY2017Q1	us-gaap	Stockholders Equity StockholdersEquity	261940000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	334413000	USD
CY2017Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	674000	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	789000	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	670000	USD
CY2016Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	60073000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	59693000	shares
CY2017Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	61868000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	61703000	shares
CY2016Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	58938000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	58338000	shares
CY2017Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60562000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60160000	shares

Files In Submission

Name	View Source	Status
0001428336-17-000028-index-headers.html	Edgar Link	pending
0001428336-17-000028-index.html	Edgar Link	pending
0001428336-17-000028.txt	Edgar Link	pending
0001428336-17-000028-xbrl.zip	Edgar Link	pending
exhibit311-ceo302x1031.htm	Edgar Link	pending
exhibit312-cfo302x1031.htm	Edgar Link	pending
exhibit321-ceo906x1031.htm	Edgar Link	pending
exhibit322-cfo906x1031.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
hqy-20171031.xml	Edgar Link	completed
hqy-20171031.xsd	Edgar Link	pending
hqy-20171031_cal.xml	Edgar Link	unprocessable
hqy-20171031_def.xml	Edgar Link	unprocessable
hqy-20171031_lab.xml	Edgar Link	unprocessable
hqy-20171031_pre.xml	Edgar Link	unprocessable
hqy-2017x10x3110q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HQY
HEALTHEQUITY, INC. Stock $hqy

2017 Q4 Form 10-Q Financial Statement

#000142833617000028 Filed on December 07, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HQY HEALTHEQUITY, INC. Stock $hqy

2017 Q4 Form 10-Q Financial Statement

#000142833617000028 Filed on December 07, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HQY
HEALTHEQUITY, INC. Stock $hqy